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http://dx.doi.org/10.1016/j.gmbhs.2Abstract This study investigated oxidative stress-mediated alterations in the reproductive
profile of streptozotocin-induced diabetic albino rats and their amelioration by the polyherbal
formulation MTEC (modified), constituted with n-hexane fractions of hydromethanol extracts
of Musa paradisiaca roots, Tamarindus indica seeds, Eugenia jambolana seeds, and Coccinia
indica leaves in a specific ratio. We noted a change in serum insulin levels and a modulation
in carbohydrate metabolic parameters, i.e. increased fasting blood glucose level, elevated
glucose-6-phosphatase and lactate dehydrogenase activities, along with a diminution of hexo-
kinase and glucose-6-phosphate dehydrogenase activities in liver, skeletal muscle, and cardiac
muscle, which confirmed the streptozotocin-induced diabetic state. Glycogen levels were
decreased in the liver and skeletal tissues. A diminution in reproductive function in the dia-
betic state was reflected here by significant low values in reproductive organo-somatic indices,
sperm count, and motility, along with serum testosterone, but high levels of testicular choles-
terol and seminal vesicular fructose. A diminution in activity of the principal antioxidative en-
zymes along with increased levels of free radical products in the primary and accessory sex
organs, as well as in sperm pellets, also confirmed the development of oxidative stress in
the male reproductive organs. An increased expression of testicular proapoptotic Bax gene
in diabetes also supports the elevation of testicular germ cell apoptosis in the diabetic state.
Oral administration of the herbal drug MTEC (modified) at a dose of 10 mg/0.5 mL 2% Tween 80
per 100 g body weight twice daily to the diabetic rats for 28 days significantly corrected theof Bio-Medical Laboratory Science & Management (UGC Innovative Programme Funded Department),
02, West Bengal, India.
hoo.co.in (D. Ghosh).
an Genomic Medicine and Biomarker Society. Published by Elsevier Taiwan LLC. All rights reserved.
013.04.007
Diabetic therapeutic efficacy of polyherbal MTEC 55serum insulin level and carbohydrate metabolic parameters. MTEC (modified) also corrected
reproductive activities by increasing organo-somatic indices, sperm count, motility, levels of
serum testosterone, testicular cholesterol, and seminal vesicular fructose toward their respec-
tive control values. Oxidative stress-mediated testicular deformities in diabetes were rectified
by treatment with MTEC (modified), as shown here by the increasing activities of antioxidative
enzymes and decreasing levels of lipid peroxidative end-products, along with a downregulated
pattern of proapoptotic Bax-a protein in testicular tissue, without any development of
toxicity. Thus, MTEC (modified) has promising hyperglycemic, antioxidative, and antiapoptotic
activities for curing diabetes-induced testicular disorders in a streptozotocin-treated diabetic
rat model.
Copyright ª 2013, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Diabetes is a very common endocrine disorder that poses a
serious challenge to healthcare worldwide. Diabetes mel-
litus is a multidimensional disease known as a “syndrome.”
It is an endocrine and chronic metabolic disorder charac-
terized by a chronic hyperglycemic state resulting from a
malfunction of insulin secretion and/or insulin action
caused by impaired regulation of carbohydrate, lipids, and
protein homeostasis.1 It is now the seventh greatest killer
of mankind due to its high prevalence and mortality.2
Diabetes mellitus has a detrimental effect on sexual
function, especially in male individuals. Alterations in male
reproductive functions develop in diabetes as it modulates
the endocrine control of spermatogenesis by imposing an
oxidative stress that results in decreased libido, delayed
sexual maturation, and infertility with poor semen quality.3
Stages of spermatogenesis including Stages IXeXI are also
affected, and a significant increase in the number of
degenerated germ cells at various stages of development
has also been noted in diabetes mellitus,4 with decreased
levels of serum gonadotropins and testosterone.5 Although
the exact mode of regulation of male reproductive function
by insulin is still unclear, there is a positive relationship
between free testosterone and fasting insulin levels in
diabetic men independent of age, obesity, and body fat
distribution.6 Prospective studies have shown that low
testosterone levels predict the development of diabetes in
men.6
Reactive oxygen species (ROS) play an important role in
the normal function and pathophysiology of sperm.
Elevated levels of ROS are related to peroxidative damage
of the spermatozoal membrane, rich in docosahexaenoic
acid7 and susceptible to ROS, which leads to an increase in
permeability of the sperm membrane, morphologic abnor-
malities, and impaired fertility. The ultimate results are
severe oligospermia, asthenospermia, and male infertility.8
The relationship between human aortic endothelial cell
cultures with a high glucose concentration and apoptotic
phenomena has been proved by in vitro study.9 Increased
levels of expression of Bax gene in human diabetic retinas
and in the kidney cortex in diabetic animal models corre-
late with high levels of glucose.10 Apoptosis of testicular
germ cells balances the number of germ cells during the
normal process of spermatogenesis. However, in responseto death signals, for example hormonal deprivation and
pathologic stress, the mitochondrial pathway of germ cell
apoptosis is modulated by proapoptotic Bax protein by
increasing the release of cytochrome C and/or endoplasmic
reticulum-mediated Ca2þ,11 which leads to testicular
damage.
Despite progress in the management of diabetes by syn-
thetic drugs, the search for improved, safe, and natural
antidiabetic agents is still ongoing and has also been recom-
mended by the World Health Organization.12 In line with
this, we have formulated MTEC (modified), which is a com-
posite of the solvent fractions of specific plant parts. Musa
paradisiaca Lam. (familydMusaceae) is a tree-like herb
distributed throughout India and Malaysia. Different parts of
theplantare claimed tohavemedicinal values.13Wehave also
reported the antidiabetic activity of M. paradisiaca root.14
Tamarindus indica Linn. (familydCaesalpiniaceae) and
Eugenia jambolana (E. jambolana) Linn. (familydMyrtaceae)
areboth tree-typeplantswhose seedsareusedas a traditional
medicine for the management of diabetes mellitus, as re-
ported by us15,16 and others.17 Coccinia indica Wight & Am
(familydCucurbitaceae) is a herb widely distributed all
through India, and its medicinal values have been supported
by our findings.18
These four plants are used in folk medicinal practice to
treat diabetes mellitus in remote villages in West Bengal,
India. We have already reported the antidiabetic activity
of “MTEC” (which takes its name from the first letters of
the scientific name of each plant used here), a polyherbal
formulation we prepared by taking the crude aqueous
methanolic extract of these four plants in a ratio of
2:2:1:1 (w/w), respectively.19 Following our previous
success, this study was designed to develop a more potent
form of MTEC, using n-hexane fractions of hydromethanol
extracts of these four plant parts in a ratio of 2:2:1:1 (w/
w), respectively, that would have a low dose of efficacy
for the management of diabetes and diabetes-induced,
oxidative stress-related, apoptosis-mediated testicular
dysfunction.
In drug development, one of the important steps is
isolation of the more effective biomolecule(s) present in
the plant parts. To this end, effective fractions have been
identified that will provide a clue for the pharmaceutical
industry in formulating an effective herbal drug against
diabetes. The philosophy of using a polyherbal formulation
56 K. Chatterjee et al.over a monoherbal drug has been adopted here, as previ-
ously reported by us.18 These fractions are more effective
for this purpose than other fractions that have been studied
using a dose- and duration-dependent trial-and-error
method.
Materials and methods
Plant material and herbal formulation of MTEC
Fresh roots, seeds, and leaves of M. paradisiaca, T. indica,
E. jambolana, and C. indica were collected from rural areas
of Paschim Medinipur district, West Bengal, India during
May to July. Preliminary identification of the plants was
made by a taxonomist in the Botany Department, Vidyasa-
gar University, Midnapur, India. A voucher specimen (HPCH
No. 7, 1, 6, 8) was deposited in the Department of Botany at
Vidyasagar University.
After collection, the plant parts were separated and
washed thoroughly first with tap water and then with
deionized water. The plant parts were finally completely
dried in an incubator at 37C. About 6.2 kg of dried roots,
4.0 kg of dried leaves, and 4.8 kg of each of the dried seeds
were collected from 11.6 kg of fresh roots, 20 kg of fresh
leaves, and 5.3 kg and 6 kg, respectively, of fresh seeds.
The dried plant parts were pulverized separately with an
industrial electrical grinder, Then, using a 20-L percolator,
maceration was carried out separately in hydromethanol
solvent (H2O:MeOH 40:60, v/v, 250 mL of solvent being used
for 50 g of each plant part), with intermittent stirring for
the first 2 hours and left without stirring for 36 hours at
37C to avoid any degradation or deactivation of the active
component(s).
The extraction process for each plant part was continued
for the 3 days following the previous process, and the final
extracts were collected separately on the 4th day. The ex-
tracts were then filtered through first a cotton filter and then
a No. 1 Whatman filter paper in the form of slurry. The
hydromethanol filtrate was evaporated under reduced pres-
sure (10e200 mbar) using a rotatory evaporator instrument
(Hahn-Shin HS-2000NS; Pung-Dong, Gyeonggido, Korea) at
38C for complete removal of methanol. Finally, plain
aqueous filtrates were lyophilized on a VirTis bench top K
lyophilizer (SP Scientific, Warminster, PA, USA). The respec-
tive plant parts with lyophilized residues of hydromethanol
filtrates obtained with 810 g, 700 g, 800 g, and 890 g.16
The lyophilized extracted powders were then subjected
to fractionation with 2 L of laboratory grade n-hexane
solvent. These fractions were then dried in a partial vac-
uum at 38C to produce final fractions of 9.07 g, 5.30 g,
3.09 g, and 4 g, respectively, collected as solvent-free
residues into amber-colored glass containers.16 The poly-
herbal antidiabetic drug MTEC was then formulated using
these solvent fractionates of the above four plant parts in a
ratio of 2:2:1:1 (by weight), respectively.
Test animals
Normoglycemic male albino Wistar rats aged 2 months and
weighing about 130  10 g were used in these experiments.
Theanimalswerehoused in cages at anambient temperatureof 25  2C with a 12-hour light/12-hour dark cycle, and
acclimated to these conditions for 15 days before being used
in the trials. Rats were fed food and water ad libitum. The
principles of laboratory animal care and instruction given by
our Institutional Ethics Committee (VU/IAEC/ BioMed/08/
2008-2009)16 were followed throughout the experiment.Induction of diabetes mellitus, animal grouping and
treatment
Initially, 30 normoglycemic rats were selected for this
study, 24 of which were subjected to 18 hours of fasting
and induction of diabetes by a single intramuscular injec-
tion of streptozotocin (STZ; Sigma-Aldrich, St. Louis, MO,
USA) at a dose of 3.5 mg/100 g body weight in citrate
buffer (pH 4.5) as standardized by previous work in our
laboratory.16,18
Diabetes was confirmed by estimation of fasting blood
glucose (FBG) level after an interval of 24 hours and then on
the 7th day after the day of injection to investigate the
stability of the diabetic condition. Rats with an FBG greater
than 250 mg/dL but less than 350 mg/dL were included in
this investigation. Out of 24 rats, 20 rats were found to be
diabetic, and of these, 18 diabetic rats and six normogly-
cemic rats were included in the study. The experiment
lasted 28 days. The initial body weight of all 24 rats was
recorded, and they were then divided into the following
four equally sized groups:
 Group I (control group): Rats received a single intra-
muscular injection of citrate buffer (0.1 mL/100 g of
body weight for each rat).
 Group II (untreated diabetic group): Rats were made
diabetic by a single intramuscular injection of STZ at a
dose of 3.5 mg/0.l mL of citrate buffer/100 g body
weight for each rat.
 Group III (MTEC-treated diabetic group): Diabetic rats
were treated with MTEC by gavage in the fasting state
at a dose of 10 mg/0.5 mL of 2% Tween 80 per 100 g of
body weight for each rat twice a day on and from the
7th day for the next 28 days.
 Group IV (glibenclamide-treated diabetic group): Dia-
betic rats were treated with standard drug glibencla-
mide by gavage in the fasting condition at a dose of 6
mg/0.5 mL of 2% Tween 80 per 100 g of body weight for
each rat twice a day on and from the 7th day for the
next 28 days.
Groups I and II were subjected to forceful feeding of
0.5 mL of 2% Tween 80/100 g of body weight twice a day for
28 days at the time when the animals in Groups III and IV
were being treated with MTEC or glibenclamide, to keep all
the animals under the same experimental conditions.
Every day, the first oral dose of the above-mentioned
formulation was given at 7 AM, one hour before supplying
the animal feed in the morning at 8:00 AM. A second oral
dose was administered at 7 PM, two hours after cleaning
the feed box in the afternoon at 5:00 PM. Feed was supplied
again to the animals 1 hour after the second oral adminis-
tration of the formulation and feed box was separated from
the cage on next day at 5 AM.
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in Group III or IV, the FBG of all the groups was monitored
using a single-touch glucometer (Ascensia Entrust; Bayer,
GmbH, Germany) at 2-day intervals. On the 29th day of the
experiment (considering the day of treatment with MTEC or
glibenclamide to be the 1st day), all the animals were
sacrificed by decapitation after recording the final body
weight and organ wet weight. Blood was collected from the
dorsal aorta by syringe, and the serum was separated by
centrifugation at 3000  g for 5 minutes to assess insulin
level and metabolic toxicity parameters. Packed cell pel-
lets were used to measure glycated hemoglobin (HbA1c).
The testes, caudae epididymides, and seminal vesicles
were removed and weighed to measure the organo-somatic
index (organ weight  100/body weight). The liver, skeletal
muscle, and cardiac muscles were dissected out, wet
weights were noted separately, and the samples were
stored at e20C for biochemical analysis of the carbohy-
drate metabolic enzymes. One testis of each animal was
fixed in Bouin’s fixative for histologic study. Using a sus-
pension medium, sperm were washed out from the cauda
epididymis to monitor sperm count and motility, and for
sperm pellet preparation. The remaining testis and the
epididymis of each animal were used for western blot
analysis and biochemical study, as well as for assessment of
the activities of the antioxidative enzymes catalase,
peroxidase, superoxide dismutase (SOD), and glutathione S-
transferase (GST), and for quantification of levels of con-
jugated diene (CD) and thiobarbituric acid reactive sub-
stance (TBARS) in the target tissues. Seminal vesicular fluid
was used for fructose quantification.
Measurement of hyperglycemic profile
FBG was measured using the single-touch glucometer by
collecting blood from the tip of the tail of all experimental
and control animals in all groups on starting day of the
experiment and there after at every 2 days interval
throughout the experiment.18 Serum insulin level was
measured using a solid phase-conjugated sandwich enzyme-
linked immunosorbent assay (ELISA) kit for rats (EZRMI-13K;
Millipore, St.Charles, Missouri, USA).20 HbA1c level and he-
patic and skeletal tissue glycogen content were measured
following our laboratory standard protocol.18,21 The activ-
ities of the principal carbohydrate metabolic enzymes
hexokinase, glucose-6-phosphatase, glucose-6-phosphate
dehydrogenase, and lactate dehydrogenase in the hepatic,
skeletal and cardiac tissues were assayed following the
established methods used in our laboratory.16,18,21
Measurement of reproductive profile
Epididymal sperm count and sperm motility
Spermatozoa were collected from an equal length of the
cauda of the excised epididymis of each rat in all the groups
by flushing the cauda with the same volume (10 mL) of a
suspension medium containing 140 mM/L of NaCl, 0.3 mM/L
of KCl, 0.8 mM/L of Na2HPO4, 0.2 mM/L of KH2PO4, and
1.5 mM/L of D-glucose (pH adjusted to 7.3 by adding 0.1 M/L
of NaOH) (Merck, Mumbai, India). The collected sample was
centrifuged at 100  g for 2 minutes, and the precipitatewas resuspended in 10 mL of fresh medium. The number of
spermatozoa in a 100 mL suspension was counted using a
hemocytometer slide.22 The sperm count was expressed as
the number of sperm per milliliter of suspension. The
number of motile spermatozoa in 100 mL of suspension was
counted under the microscope after placing the sample on
a glass slide and covering it with a cover slip.22 The result
was expressed as a percentage after counting 100 sperm in
each field.
Quantification of seminal vesicular fructose level
Seminal vesicular homogenate was prepared at a tissue
concentration of 50 mg/mL to measure its fructose level.
The supernatant was deproteinized by adding 50 mL of
ZnSO4 and 50 mL of NaOH to make a total dilution of seminal
plasma of 1:16. This was followed by centrifugation at
400 g for 15 minutes. For fructose measurement, 200 mL
of this clear supernatant was used. The optical density of
the standard and sample were measured against a blank at
470 nm. The concentration of fructose was obtained by
plotting the value on a standard curve, with the value
expressed as mM/mg of tissue.23
Estimation of testicular cholesterol level
Testicular cholesterol was estimated using the kit supplied
by Angstrom Biotech Pvt. Ltd. (Vododara, India). Choles-
terol ester present in the testicular homogenate is acted on
by cholesterol esterase to release fatty acid and choles-
terol, which is oxidized by cholesterol oxidase to produce
cholest-4-en-3-one and hydrogen peroxide. The hydrogen
peroxide, together with 4-aminoantipyrine and a phenolic
compound in the presence of peroxidase, forms the colored
complex. The intensity of the color is proportionate to the
total cholesterol level, which was measured at 505 nm.24
Assay of serum testosterone by ELISA
Serum testosterone level was measured using a solid phase-
conjugated assay by noting the optical density of standard
and unknown samples using a 480 nm selective filter and a
650 nm differentiating filter.25 The testosterone kit was
supplied by Lilac Medicare (P) Ltd (Mumbai, India). The
intra-assay variation was 5.2%. Interassay variation was not
applicable as all samples were assayed at the same time.Assessment of antioxidative enzyme and lipid
peroxidation end-product profile
Biochemical assessment of catalase, peroxidase, SOD,
and GST activities
The activities of catalase, peroxidase, SOD, and GST of the
testis, cauda epididymis, and sperm pellet were measured
biochemically following our standard laboratory method.18
Estimation of end-products of lipid peroxidation (CD and
TBARS)
The sample tissues were homogenized separately at a tis-
sue concentration of 50 mg/mL in 0.1 M of ice-cold phos-
phate buffer (pH 7.4), and the homogenates were
centrifuged separately at 10,000  g at 4C for 5 minutes.
Each supernatant was used for the spectrophotometrical
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methods. 18
Acute toxicity study and biochemical estimation of
metabolic toxicity markers glutamic oxaloacetic
transaminase (GOT) and glutamate pyruvate
transaminase (GPT)
To establish the safety profile of the formulation, an acute
toxicity study was carried out as per established guidelines.
Healthy, adult, normoglycemic male albino Wistar rats,
starved overnight, were divided into four groups of six rats
eachdcontrol, 50-mg-treated, 100-mg-treated, and 300-
mg-treated. They were orally fed with the 2% Tween 80 and
MTEC (modified) in increasing dose levels of 50, 100, and
300 mg/100 g body weight in 2% Tween 80. The rats were
kept under supervision continuously for 2 hours to record
behavioral, neurologic, and autonomic profiles, and after a
period of 24 and 72 hours for any death.26
Specific kits (Span Diagnostics Ltd., Surat, India) were
used to measure serum GOT and GPT activity as a marker of
metabolic toxicity, with the results expressed as relative
units.16,18
Western blot analysis of testicular tissues
Frozen testicular tissues were ground in ice-cold radio-
immunoprecipitation buffer (1 mL/g of tissue), and 100 mL
of protease inhibitor cocktail (Roche Applied Science,
Mannheim, Germany) was added. This was frozen at e20C,
thawed, and centrifuged at 15,000  g for 20 minutes at
4C. The supernatant was then collected. Protein content
was determined using Bradford reagent (Sigma-Aldrich, St.
Louis, MO, USA) following the Bradford method.27
Protein samples (100 mg/well) along with prestained
protein marker (5 mL) were electrophoresed on 14%
resolving gel for 2 hours at 80 V. One gel was transferred
to Coomassie Brilliant Blue stain to check the protein
profile, and the second gel, electrophoresed under iden-
tical conditions, was used for western blot analysis.
Resolved protein from the gel was transferred to the PVDF
membrane (0.45 mm; Millipore Corporation, Billerica, MA,
USA) using a semi-dry electroblotting system (Hoefer, Inc.
Holliston, MA, USA) at 150 mA for 1.5 hours. The blot was
rinsed once in Tris buffer saline (TBS; pH 7.5), andTable 1 Correction in the mean fasting blood glucose level in h
treatment with the polyherbal formulation MTEC (modified) or gl
Groups
0 Daya
Group I (Control group) 3.47  0.
Group II (Untreated diabetic group) 3.25  0.
Group III (MTEC treated diabetic group) 3.31  0.
Group IV (Glibenclamide treated diabetic group) 3.36  0.
Data are expressed as mean  standard error, n Z 6. Analysis of var
*Significant difference (p < 0.05) compared with the control group o
**Significant difference (p < 0.05) after treatment in each group in c
a STZ injections were given to the diabetic, MTEC-treated, and glib
b Treatment was started in the MTEC-treated and glibenclamide-treblocking was carried out by 5% non-fat dry milk in Tris
buffer saline with Tween 20 (TBST; pH 7.5) overnight.
Washed blot was incubated with primary mouse
monoclonal antibody (sc 7480; Santa Cruz Biotechnology,
Inc. Heidelberg, Germany) for Bax-a (21 kDa; 1:200 dilu-
tion in TBST) overnight at 4C. Incubation with rabbit
polyclonal antibody anti b-actin (A2066; 42kDa; 1:6000
dilution in TBST; Sigma-Aldrich, St. Louis, MO, USA) served
as an internal control to monitor equal loading of protein.
Incubated blot was washed twice with TBST (1% Tween 20)
and once with TBST (0.5% Tween 20) for 5 minutes each.
Blots were incubated with horseradish peroxidase (HRP)
linked goat anti-mouse, anti-rabbit secondary antibody
diluted (1:2000) in TBST (0.5% Tween 20) at room tem-
perature for 2 hours followed by washing with TBST and
Tris buffer saline (TBS), and the labeled protein bands
were visualized using the DAB system (Bangalore Genei,
Bangalore, India). Densitometric analysis was performed
with LabWorks image analysis software (Ver 4.0, UVP Inc.,
Upland, CA, USA).28Histological study
The testicular tissue was dissected out, slices being pre-
pared from the same region of all the groups and fixed in
Bouin’s fixative. These were subjected to paraffin embed-
ding after a proper dehydration process, followed by
section-cutting in a rotary microtome (4 mm thick; Semi-
automated Rotary Microtome Leica RM2245; Leica Micro-
systems GmbH, Wetzlar, Germany) and hematoxylin and
eosin staining for microscopic examination in accordance
with laboratory procedures. Histologic examination was
carried out on stained sections using AVerCap (Version 2.5;
AVerMedia Technologies Inc., Fremont, CA, USA) and
DeWinter Caliper Pro software (Version 3.0; Dewinter Op-
tical Inc., West Patel Nagar, Delhi, India).18Statistical analysis
All experimental trials were replicated three times. Anal-
ysis of variance followed by a multiple comparison two-tail
t test was used to compare the groups.18,26 Differences
were considered significant at p < 0.05.yperglycemic streptozotocin (STZ)-induced diabetic rats after
ibenclamide.
Mean fasting blood glucose level (mmol/L)
1st Day 7th Dayb 35th Day
15 3.58  0.16 3.58  0.16 3.47  0.15
12 18.13  0.81* 19.78  0.88* 19.67  0.87*
12 19.06  0.85* 19.89  0.89* 4.85  0.27**
14 18.89  0.85* 19.61  0.88* 4.74  0.21**
iance followed by a multiple comparison two-tail t test.
n the same day.
omparison with the control group.
enclamide-treated groups.
ated groups.
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Hyperglycemic profile assessment
A significant (p < 0.05) elevation in FBG was noted in un-
treated diabetic animals, the blood glucose level being
greater than 250 mg/dL, compared with nondiabetic con-
trol rats (Table 1). Treatment of diabetic animals with
MTEC (modified) or glibenclamide for 28 days resulted in a
significant (p < 0.05) lowering of FBG level (Table 1).
Serum insulin level, the glycogen content of hepatic
tissue and skeletal muscle, and the activities of hepatic,
skeletal and cardiac muscle hexokinase and glucose-6-
phosphate dehydrogenase were significantly decreased
(p < 0.05) in the untreated diabetic group in comparison
with the control group animals. Administration of the
polyherbal formulation MTEC (modified) or glibenclamide
to diabetic animals resulted in a significant (p < 0.05)
recovery of serum insulin level and glycogen content,
along with restoration of the activities of the carbohy-
drate metabolic enzymes towards control levels. The
levels of HbA1c in blood, and the activities of glucose-6-
phosphatase and lactate dehydrogenase in the above-
mentioned target tissues, in untreated diabetic rats
were higher than, and the said values in diabetic rats were
decreased significantly (p < 0.05) towards the control
levels after treatment with MTEC or glibenclamide
(Table 2, Fig. 1).
Reproductive profile screening
Biomarkers for monitoring semen quality, for example
sperm count and sperm motility, were significantly
decreased (p < 0.05) in untreated diabetic rats in com-
parison to the control rats, which were increased signifi-
cantly (p < 0.05) toward control levels in MTEC (modified)-
or glibenclamide-treated diabetic rats (Table 3).
Significantly decreased (p < 0.05) levels of serum
testosterone along with increased testicular cholesterol
and seminal vesicular fructose levels were found in the
diabetic group with respect to controls, and were signifi-
cantly (p < 0.05) rectified toward control levels
after treatment with MTEC (modified) or glibenclamide
(Table 3).Table 2 Effect of the polyherbal formulation, MTEC (modifi
streptozotocin-induced diabetic rats.
Group Glycated
hemoglobin
(mmol/mol)
Group I (Control group) 2.95  0.02
Group II (Untreated diabetic group) 29.07  1.39
Group III (MTEC treated diabetic group) 11.04  0.60
Group IV (Glibenclamide treated diabetic group) 11.70  0.65
Data are expressed as mean  standard error, n Z 6. Analysis of var
*Significant difference (p < 0.05) compared with the control group.
**Significant difference (p < 0.05) after treatment in each group com
***Significant difference (p < 0.05) after treatment in each group comOxidative stress markers profile assessment
Activities of catalase, peroxidase, SOD, and GST in the
testis, cauda epididymis, and sperm pellet were signifi-
cantly (p < 0.05) decreased in the diabetic group in com-
parison to the control group. When STZ-treated diabetic
rats were treated with the polyherbal formulation MTEC
(modified) or glibenclamide, the levels of these parameters
were restored significantly (p < 0.05) toward the control
levels (Fig. 2). Levels of end-products of lipid peroxidation,
i.e. CD and TBARS, in the reproductive tissues and sperm
pellet were significantly increased (p < 0.05) in the dia-
betic group when compared to the control group. There
was a significant (p < 0.05) recovery in the levels of the
above parameters in the target tissues after treatment with
MTEC (modified) or glibenclamide to the animals in the
diabetic group (Fig. 2).
Western blot analysis
Western blot densitometric analysis of protein expression
of the apoptosis biomarker Bax-a also indicated an
increased level of testicular apoptosis in the diabetic rats
when compared to control rats. A significant (p < 0.05)
remedial activity of MTEC (modified) or glibenclamide on
protein expression was noticed in the target tissues after
treatment of the animals in the diabetic group (Fig. 3).
Histological study
Degeneration in the germ cell layers in the seminiferous
tubules was observed in the diabetic rats with respect to
the control group rats, and was corrected to some extent in
qualitative terms after treatment of the diabetic rats with
MTEC (modified) formulation or glibenclamide (Fig. 4).
Analysis of body weight and reproductive organo-
somatic indices
The body weight and reproductive organo-somatic indices of
the diabetic animals were decreased in comparison with the
control group. Treatment of diabetic rats with MTEC (modi-
fied) or glibenclamide twice a day for 28 days corrected the
decrease inbodyweight andorgano-somatic indices (Table 4).ed) or glibenclamide on biomarkers of hyperglycemia in
level
Glycogen
(mg of glucose/mg of tissue)
Serum insulin level
(pM)
Liver Muscle
11.0  0.51 7.11  0.33 738.50  29.75
* 4.90  0.22* 2.82  0.13* 351.75  15.75*
** 6.11  0.28** 4.28  0.19** 553.00  24.50**
** 7.19  0.38*** 4.51  0.21** 563.50  24.50**
iance followed by a multiple comparison two-tail t test.
pared with the control group.
pared with the control group.
Figure 1 Amelioration in the activities of carbohydrate metabolic enzymes (hexokinase, glucose-6-phosphate dehydrogenase,
glucose-6-phosphatase, and lactate dehydrogenase) in liver and skeletal and cardiac muscle after treatment with MTEC (modified)
or glibenclamide in streptozotocin-induced diabetic rats. Analysis of variance followed by multiple comparison two-tail t test. Bars
represent mean  standard error (n Z 6 for each group). Bars with different letters (a, b, c) differ significantly from each other
(p < 0.05).
60 K. Chatterjee et al.Acute toxicity study and biochemical estimation of
metabolic toxicity markers
MTEC (modified) at its maximum dose level of 300 mg/100 g
of body weight did not produce any significant changes inTable 3 Correction in reproductive profile (sperm count, sperm
and serum testosterone levels) after treatment with the polyher
zotocin-induced diabetic rats.
Group Sperm count
(Million/mL
epididymal fluid)
Sper
moti
Group I (Control group) 20.77  1.01 76.16
Group II (Untreated diabetic group) 8.21  0.37* 31.81
Group III (MTEC treated diabetic group) 14.33  0.65** 61.11
Group IV (Glibenclamide
treated diabetic group)
13.81  0.62** 64.22
Data are expressed as mean  standard error, n Z 6. Analysis of var
*Significant difference (p < 0.05) compared with the control group.
**Significant difference (p < 0.05) after treatment in each group comautonomic, behavioral, or neurologic parameters. Acute
toxicity studies revealed the nontoxic nature of the MTEC
(modified) formulation.
Activities of serum GOT and GPT were found to be un-
altered (p > 0.05) in all the groups treated with themotility, and seminal plasma fructose, testicular cholesterol,
bal formulation MTEC (modified) or glibenclamide in strepto-
m
lity (%)
Seminal vesicular
fructose level
(mM/mg of tissue)
Testicular
cholesterol
level (mg/dL)
Serum
testosterone
level (nmol/L)
 3.41 2.61  0.12 35.78  1.61 0.066  0.0030
 1.41* 4.73  0.23* 47.23  2.17* 0.002  0.0001*
 2.73** 3.27  0.15** 38.13  1.74 0.012  0.0007**
 2.87** 3.01  0.14** 36.07  1.61 0.013  0.0007**
iance followed by a multiple comparison two-tail t test.
pared with the control group.
Figure 2 Corrective effect of the polyherbal formulation MTEC (modified) or glibenclamide on antioxidant enzyme activities and
levels of free radical-generated end-products in testis, epididymis, and sperm pellet in streptozotocin-induced diabetic rats.
Analysis of variance followed by multiple comparison two-tail t test. Bars represent mean  standard error (nZ 6 for each group).
Bars with different letters (a, b, c, d) differ significantly from each other (p < 0.05).
Diabetic therapeutic efficacy of polyherbal MTEC 61polyherbal formulation MTEC (modified) in comparison to
the control group (Table 5).Discussion
This study was designed to develop the more potent and
more effective MTEC (modified) compared to our previous
formulated polyherbal drugdMTECdwhich was the
aqueous methanol extract of the equivalent plant parts, for
the management of STZ-induced diabetes.19 STZ causes aselective destruction of insulin-secreting pancreatic beta-
cells by ROS-mediated oxidative damage, resulting in
insulin-dependent diabetes mellitus.14
The elevation of FBG and HbA1c along with the diminu-
tion in levels of liver and skeletal muscle glycogen in STZ-
induced diabetic rats, due to low levels of serum insulin,
are consistent with our earlier findings.26 Diabetes induced
by hypoinsulinemia has been further increased by the
diminution in the activities of hexokinase and glucose-6-
phosphate dehydrogenase in liver, skeletal muscle, and
cardiac muscle as these enzymes are under the positive
Figure 3 Representative semiquantitative result of Bax-a
content of the testis obtained by densitometric analysis of
western blots. Lane 1: Total testicular lysate from MTEC
(modified)-treated rats. Lane 2: Total testicular lysate from
control rats. Lane 3: Total testicular lysate from
glibenclamide-treated rats. Lane 4: Total testicular lysate from
untreated diabetic rats. Analysis of variance followed by mul-
tiple comparison two-tail t test. Bars represent
mean  standard error (n Z 6 for each group). Bars with
different letters (a, b, c) differ significantly from each other
(p < 0.05) at each time period. A.D.U. Z arbitrary densito-
metric units.
62 K. Chatterjee et al.regulation of insulin.18 In parallel, the elevation in the ac-
tivities of glucose-6-phosphatase and lactate dehydroge-
nase in the above tissues in diabetes again supports
hypoinsulinemia as these sensors are under the negative
control of insulin.21
The significant diminution in reproductive organo-
somatic indices in the diabetic rats might be due to low
levels of serum testosterone29 and insulin.30,31 The diabetic
state reduces testosterone levels by suppressing the
secretion of luteinizing hormone and follicle-stimulating
hormone.30 Impairment of spermatogenesis in diabetic
rats may be due to an impairment of function of the
testicular Sertoli cells, which secrete androgen-binding
protein that retains testosterone in the seminiferous tu-
bules upon stimulation with follicle-stimulating hor-
mone.32,33 Hypoinsulinemia in diabetes also alters the
expression of aromatase enzymes in the testis,34 which help
the synthesis of testicular estradiol, an indisputable regu-
lator of spermatogenesis.34
Low sperm count and motility in diabetes may be due to
low serum insulin as insulin is one of the regulators of
testicular steroidogenesis.30 The high level of blood glucose
in diabetes produces superoxide anions and hydroxyl radi-
cals in the presence of transition metal ions, which cause
oxidative damage to cell,35 that results the diminished ac-
tivities of the antioxidative enzymes and the elevatedlevels of TBARS and CD in reproductive tissues, which re-
sults in impaired spermatogenesis. The result also may be
due to low levels of serum insulin and testosterone.36
Auto-oxidation of glucose and nonenzymatic glycation
increases the production of hydrogen peroxide and the
superoxide radical (O2 ), which decrease the activities of
the principal antixoidative enzymes SOD, peroxidase,
catalase, and GST in the diabetic condition.37 The
decreased enzyme activity of SOD further enhances the
production of O2 in the target tissues.
38 Diminution in the
activity of peroxidase results in decreased protection
against ROS.16,39 In the highly pro-oxidant diabetic envi-
ronment, the reduced enzyme activity of catalase might be
due to this elevated level of O2.
40 The reduced activity of
the GST enzyme in hyperglycemic conditions also fails to
detoxify endogenous compounds such as peroxidized
lipids.41 In diabetes, hypoinsulinemia increases the activity
of the enzyme fatty acyl coenzyme A oxidase, which initi-
ates the beta-oxidation of fatty acids, resulting in lipid
peroxidation.37 Further, the induction of oxidative stress in
the testis and sperm in the diabetic state might be due to
the high level of uncoupler protein synthesis in sperm, or
due to a hypoxic state as diabetes results in HbA1c forma-
tion that interferes with oxygen delivery at the target
tissues.42
Programmed cell death, or apoptosis, plays a critical
role in normal spermatogenesis.43 Previous studies have
proved that oxidative stress induced by a high glucose
concentration triggers events associated with the proapo-
ptotic protein Bax, including subsequent caspase activation
and an abnormal progression to apoptotic cell death.44 In
addition, hyperglycemia downregulates the glucose trans-
porters GLUT1, GLUT2, and GLUT3, triggering the mito-
chondrial death cascade pathway.45 An interdependent
relationship has been established between increased levels
of FBG, HbA1c, and overexpression of Bax protein that
magnifies cell death by endothelial dysfunction in dia-
betes.46 Present findings from the densitometric analysis of
testicular proapoptotic Bax-a protein expression strongly
support all these relationships.
The increased fructose levels in seminal plasma seen in
diabetes may be due to impaired fructose utilization in line
with a low sperm count, which has also been shown in
previous works.47 Our results showed that, in diabetes, the
tuning system of the pituitaryetesticular axis has been
blunted and finally leads to infertility.
Previous reports have shown that diabetes mellitus
cannot be totally managed by a single chemical or ingre-
dient but by multiple chemicals or ingredients,48 as sup-
ported by our results of treatment with the polyherbal
formulation MTEC (modified). The effect might be due to a
restoration of serum insulin levels towards control values,
which is also supported by our findings and is in parallel
with our previous reports.26 Phytoingredients such as alka-
loids, flavonoids, and gallic acid from the different plant
parts used to constitute MTEC (modified) have high antidi-
abetic and antioxidant capacities, 16,49,50that help this
polyherbal formulation to offer protection against diabetes
and its related complications. Elevated insulin levels and
glycogen levels in hepatic tissue and skeletal muscle, as
well as a restoration of the activities of the carbohydrate
metabolic enzymes that are under the positive regulation
Figure 4 Histology of the testis (H&E stain, 400). (A) Representative sample of testicular sections in Stage VII of spermato-
genesis showing a normal arrangement of different generations of germ cells in the seminiferous tubules of the control group.
(B) Representative sample of testicular sections showing a diminution in number and disarrangement of different generations of
germ cells at Stage VII in the diabetic group. (C) Representative sample of testicular sections in Stage VII showing recovery of the
number of different generations of germ cells in the MTEC (modified)-treated group. (D) Representative sample of testicular
sections in Stage VII showing recovery of the number of different generations of germ cells in the glibenclamide-treated group.
Diabetic therapeutic efficacy of polyherbal MTEC 63of insulin after treatment with MTEC (modified), also indi-
cate the insulinotropic activity of this polyherbal
formulation.15,16
The mechanism of beta-cell protection from the dele-
terious effect of STZ by MTEC (modified) may be explained
by the fact that the phytoingredients present in the plant
parts may increase the production of transforming growth
factor-b1 (TGF-b1) in the plasma in type 1 diabetes. ThisTable 4 Rectification of body weight and reproductive organo
lation MTEC (modified) or glibenclamide in streptozotocin-induce
Groups Body weight (g)
Initial Final
Group I (control group) 127  5.5 131  5.
Group II (diabetic group) 124  5.4 116  5.
Group III (MTEC-treated group) 123  5.4 129  5.
Group IV (glibenclamide-treated group) 122  5.4 127  5.
Data are expressed as mean  standard error, n Z 6. Analysis of var
*Significant difference (p < 0.05) compared with the control group.
**Significant difference (p < 0.05) after treatment in each group com
***Significant difference (p < 0.05) after treatment in each group comcontributes to the formation of a TGF-b1 ring around the
pancreatic islets that protects the beta-cells against infil-
trating lymphocytes, providing a safe environment for the
promotion of beta-cell regeneration and increased serum
insulin.51 Another possible mechanism in this concern is the
inhibitory effect on hepatic insulinase enzyme activity that
increases peripheral utilization of glucose by increasing
plasma insulin.-somatic indices after treatment with the polyherbal formu-
d diabetic rats.
Testiculo-somatic
index (g%)
Epididymis
somatic
index (g%)
Seminal
vesiculo-somatic
index (g%)
9 3.46  0.17 0.667  0.03 0.432  0.02
1 1.04  0.05* 0.392  0.02* 0.184  0.01*
7 1.82  0.11** 0.548  0.03** 0.338  0.02**
6 1.79  0.11** 0.519  0.02** 0.311  0.02**
iance followed by a multiple comparison two-tail t test.
pared with the control group.
pared with the control group.
Table 5 Study of general and metabolic toxicity bio-
markers (serum glutamate pyruvate transaminase and glu-
tamic oxaloacetic transaminase activities) after treatment
with increasing doses of the polyherbal formulation MTEC
(modified) in normoglycemic Wistar rats.
Groups SGPT (U/L) SGOT (U/L)
Group I (Control group) 35.2  1.56 12.9  0.47
Group II (50 mg MTEC
treated group)
36.0  1.56 13.0  0.47
Group III (100 mg MTEC
treated group)
36.2  1.56 13.4  0.47
Group IV (300 mg MTEC
treated group)
37.3  1.57 13.0  0.47
Data are expressed as mean  standard error, nZ 6. Analysis of
variance followed by a multiple comparison two-tail t test.
Values do not differ from each other (p > 0.05) when compared
with the control group.
64 K. Chatterjee et al.Although glibenclamide is a common drug of choice in
the treatment of type 2 diabetes, its hypoglycemic effect in
STZ-induced diabetes, a model of type 1 diabetes, is also
well documented.52e54 In studies of insulin-dependent
diabetes in rats with partially preserved synthesis of insu-
lin treated with glibenclamide stimulates insulin secretion
and reduces hepatic glucose production, resulting in
reduced blood glucose levels. It increases the release of
insulin as a response to serum glucose level. Glibenclamide
binds to the surface receptors of the beta-cell membrane,
inhibits ATP-sensitive potassium channels, and causes de-
polarization of the cell membrane, which enables extra-
cellular calcium to enter into the cell. Increased
intracellular calcium concentrations enhance the binding of
calcium to the transport protein calmodulin, which helps to
release insulin-containing granules.55 MTEC formulation
may also stimulate insulin secretion following this
phenomenon.
A recovery of organo-somatic indices, correction of the
sperm count and motility, and arrangement of different
stages of germ cells in spermatogenesis in the seminiferous
tubules toward control values were noted after treatment
with our polyherbal formulation or glibenclamide. Thismight
be due to a correction of serum insulin levels that restored
the testicular androgenesis process.30 This elevated insulin
level corrected the process of spermatogenesis by enhancing
the upregulation of testosterone synthesis, similar to other
experiments in which insulin injections to diabeticmice gave
rise to an increase in serum gonadotropin and testosterone
levels.56 It was also supported in our study by a rise in the
level of serum testosterone and a lowering of testicular
cholesterol level, along with a histologic study of testicular
sections in Stage VII of spermatogenesis showing a normal
arrangement of the different generations of germ cells in the
seminiferous tubules.
Testicular oxidative stress in the diabetic state that re-
sults in spermatogenic impairment recovered toward con-
trol levels after treatment with MTEC (modified) same as
glibenclamide. Both the polyherbal formulation and gli-
benclamide treatment reduced blood glucose level,
increased antioxidant enzyme activity,29 decreased theformation of ROS, and protected target cells from oxidative
damage by scavenging the end-products of free radical
generation (CD and TBARS). Treatment also inhibited
expression of the proapoptotic protein Bax-a in the gonads,
resembling previous findings.57 After treatment, the
increased activities of SOD, peroxidase, catalase, and GST
might be a protective mechanism in response to increased
concentrations of hydrogen peroxide and other lipid per-
oxides, strongly associated with a normalization of hyper-
glycemia by insulinotropic mechanisms as insulin regulates
the activities and expression of all these antioxidant en-
zymes,58 and prevents microvascular complications that
produce oxidative stress.59 This might be explained by the
phenomenon of “glycemic or metabolic memory,”60 and
this glycemic memory might be responsible for the
ameliorative activity of MTEC or glibenclamide; this is
supported by the elevated levels of CD and TBARS in dia-
betic rats with poor glycemic control and a normalization of
these parameters in treated diabetic rats, leading to good
glycemic regulation compared to controls.61
Alkaloids, flavonoids, and gallic acid, the phytoing-
redients of the different plant parts used to constitute
MTEC (modified), have high antioxidant capacities,16,49,50
and this helped this polyherbal formulation to offer pro-
tection against oxidative stress. The antiapoptotic poten-
tiality against elevated Bax protein expression was
attenuated by MTEC (modified) or glibenclamide by insuli-
notropic activity as an inverse relationship between insulin
and Bax protein expression has been established in STZ-
induced diabetic rats.62
The decrease in level of seminal vesicular fructose after
treatment with MTEC (modified) demonstrated the correc-
tion in fructose synthesis, and its utilization by sperm was
reflected in an increased sperm function count and motility
as it is the main biofuel for sperm.
MTEC (modified) has no toxicity shown here in the acute
toxicity study, as well as in the study of serum GOT and GPT
activities, these being indicators of general and metabolic
toxicity.18Conclusions
Our formulated modified MTEC offered remedial profi-
ciency in terms of glycemic homeostasis as well as atten-
uation of reproductive dysfunction in a comparatively low
dose in comparison to our previously formulated MTEC. The
possible mode of action of this polyherbal formulation in
producing a therapeutic effect in diabetes is the enhance-
ment of insulin secretion by a regeneration of beta-cells in
the pancreatic islets; this is supported here by an elevation
in serum insulin level and an upregulation of carbohydrate
metabolic enzymes that are under positive regulation by
insulin. This rectifies the FBG level and HbA1c level and
results in the re-establishment of homeostasis of carbohy-
drate metabolism. In terms of the restitution of the histo-
architecture and androgenic profile of the testicular tissue
during oxidative stress and in terms of apoptotic mecha-
nisms, METC (modified) improves sperm quality parameters
and rectifies diabetes-induced male infertility. Its biosafety
profile has also been established.
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